Salicylic Acid

Description

No description information is available.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot and disrupt the normal footprint pattern.

Limitations of Use: There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely. A small amount of the wart remover should then be applied using the provided applicator, ensuring that each wart is sufficiently covered.

This application should be allowed to dry, and the procedure may be repeated once or twice daily. Treatment can continue until the wart is removed, with a maximum duration of up to 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product except under the advice and supervision of a healthcare professional, as there is an increased risk of complications. Application on irritated, infected, or reddened skin is contraindicated due to the potential for exacerbating these conditions. The presence of genital warts, facial warts, moles, birthmarks, or warts with hair growth also contraindicates use, as these may indicate underlying issues that require different management. Additionally, application to mucous membranes is not recommended due to the risk of irritation and adverse reactions.

When using this product, it is essential to avoid contact with the eyes; in the event of contact, the eyes should be flushed with water for 15 minutes. Inhalation of vapors should also be avoided to prevent respiratory irritation.

Warnings and Precautions

For external use only, this product is flammable and should be kept away from fire or flame. It is essential to cap the bottle tightly and store it at room temperature, away from heat sources.

General precautions must be observed to ensure safe use. This product should not be used by individuals with diabetes or poor blood circulation unless under the advice and supervision of a qualified healthcare professional, such as a doctor or podiatrist. It is contraindicated for application on irritated, infected, or reddened skin, as well as on genital warts, facial warts, moles, birthmarks, and warts with hair growing from them. Additionally, this product should not be applied to mucous membranes.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Users should discontinue use and consult a healthcare provider if discomfort persists.

Side Effects

For external use only. Patients should be advised that the product is flammable; therefore, it must be kept away from fire or flame. The bottle should be capped tightly and stored at room temperature, away from heat sources.

The product should not be used by individuals who are diabetic or have poor blood circulation, unless under the advice and supervision of a doctor or podiatrist. It is contraindicated for use on irritated, infected, or reddened skin, as well as on genital warts, warts on the face, moles, birthmarks, and warts with hair growing from them. Additionally, it should not be applied to mucous membranes.

While using the product, patients should avoid contact with the eyes. In the event of contact, the eyes should be flushed with water for 15 minutes. Inhalation of vapors should also be avoided.

Patients are advised to stop use and consult a doctor if discomfort persists. It is important to keep the product out of reach of children. If swallowed, medical help should be sought immediately, or contact a Poison Control Center.

Drug Interactions

There are currently no documented drug interactions or interactions with laboratory tests associated with this medication. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time. Healthcare professionals should continue to assess individual patient circumstances and consider any potential interactions based on the patient's overall medication regimen.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (wart remover liquid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should be advised against the use of this product if they have diabetes or poor blood circulation, unless under the guidance and supervision of a healthcare professional, such as a doctor or podiatrist. The safety of this product during pregnancy has not been established, and its use is contraindicated on irritated, infected, or reddened skin. Additionally, it should not be applied to genital warts, facial warts, moles, birthmarks, or warts with hair growing from them. The product is also not intended for use on mucous membranes. Healthcare providers should carefully consider these factors when advising pregnant patients regarding the use of this product.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. It is recommended to weigh the potential benefits against any unknown risks to breastfed infants.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed that the product is not recommended for use in individuals with diabetes or poor blood circulation unless under the guidance and supervision of a healthcare professional, such as a doctor or podiatrist. It is also important to instruct patients not to apply the product on irritated, infected, or reddened skin, as well as on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, the product should not be used on mucous membranes.

Patients should be counseled to discontinue use and consult a doctor if discomfort persists after application. When using the product, it is crucial to avoid contact with the eyes; if the product does come into contact with the eyes, patients should flush them with water for 15 minutes. Furthermore, patients should be cautioned against inhaling vapors while using the product to ensure their safety.

Storage and Handling

The product is supplied in a tightly capped bottle. It is essential to store the bottle at room temperature, ensuring it is kept away from heat sources. The recommended storage temperature range is between 20°C to 30°C (68°F to 86°F). Additionally, it is crucial to keep the product away from fire or flame to maintain safety and integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)